2018\u5e749\u670819\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u30019\u670816\u65e5\uff5e18\u65e5\u306b\u304b\u3051\u3066\u3001\u7c73\u56fd\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u30672018 ³Ô¹Ï±¬ÁÏ R&D Summit<\/a><\/strong>\u3092\u958b\u50ac\u3057\u307e\u3059\u3002\u3053\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u306f\u30011,300\u4eba\u3092\u8d85\u3048\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u304a\u3088\u3073\u5c02\u9580\u5bb6\u306b\u304a\u96c6\u307e\u308a\u3044\u305f\u3060\u304d\u3001\u88fd\u54c1\u958b\u767a\u306e\u8fc5\u901f\u5316\u306b\u5411\u3051\u305f\u3001\u6700\u65b0\u60c5\u5831\u3092\u767a\u8868\u3057\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n \u3053\u306eSummit\u306f\u3001bluebird bio\u793e\u306e\u30c1\u30fc\u30d5\u30fb\u30d6\u30eb\u30fc\u30d0\u30fc\u30c9\u3067\u3042\u308bNick Leschly\u6c0f\u3068\u306e\u907a\u4f1d\u6027\u75be\u60a3\u304a\u3088\u3073\u5e0c\u5c11\u75be\u60a3\u306b\u304a\u3051\u308b\u753b\u671f\u7684\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u53ef\u80fd\u6027\u306b\u95a2\u3059\u308b\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u3067\u5e55\u958b\u3051\u3057\u307e\u3059\u3002\u540c\u6c0f\u306f\u3001³Ô¹Ï±¬ÁÏ\u306e\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u517c\u5171\u540c\u5275\u696d\u8005\u3067\u3042\u308bMatt Wallach\u3068\u5171\u306b\u300c\u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u3082\u305f\u3089\u3059\u75be\u75c5\u6cbb\u7642\u306e\u5177\u73fe\u5316\u300d\u3068\u3044\u3046\u30c6\u30fc\u30de\u3067\u30d5\u30a1\u30a4\u30a2\u30fc\u30b5\u30a4\u30c9\u30fb\u30c1\u30e3\u30c3\u30c8\u306b\u81e8\u5e2d\u3057\u307e\u3059\u3002<\/p>\n 100\u4eba\u3092\u8d85\u3048\u308b\u3001\u88fd\u85ac\u3001\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u304a\u3088\u3073\u533b\u7642\u6a5f\u5668\u306e\u5206\u91ce\u306b\u304a\u3051\u308b\u4e00\u6d41\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u304c\u3001\u81e8\u5e8a\u958b\u767a\u3001\u85ac\u4e8b\u304a\u3088\u3073\u54c1\u8cea\u7ba1\u7406\u306e\u5404\u696d\u52d9\u306b\u304a\u3051\u308b\u88fd\u54c1\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u306e\u52b9\u7387\u5316\u306b\u5411\u3051\u305f\u8a73\u7d30\u306a\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u3092\u5171\u6709\u3057\u307e\u3059\u3002\u4eca\u5e74\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u306f\u7279\u306b\u3001\u81e8\u5e8a\u8a66\u9a13\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u306e\u6700\u9069\u5316\u3001\u81e8\u5e8a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u518d\u69cb\u7bc9\u3001\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u8fd1\u4ee3\u5316\u304a\u3088\u3073\u85ac\u4e8b\u696d\u52d9\u306e\u5909\u9769\u306b\u95a2\u3057\u3066\u3001\u4e0b\u8a18\u306e\u3088\u3046\u306a\u57fa\u8abf\u8b1b\u6f14\u3092\u7528\u610f\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ\u306eCEO\u517c\u5275\u8a2d\u8005\u3067\u3042\u308bPeter Gassner\u306f\u57fa\u8abf\u8b1b\u6f14\u3067\u3001³Ô¹Ï±¬ÁÏ Vault\u304c\u81e8\u5e8a\u958b\u767a\u3001\u85ac\u4e8b\u3001\u54c1\u8cea\u7ba1\u7406\uff08\u8fd1\u65e5\u4e2d\u306b\u306f\u5b89\u5168\u6027\u3082\uff09\u306e\u5404\u696d\u52d9\u306b\u304a\u3044\u3066\u3001\u696d\u754c\u306e\u88fd\u54c1\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u306e\u5909\u9769\u3092\u3069\u306e\u3088\u3046\u306b\u5b9f\u73fe\u3057\u3066\u3044\u308b\u306e\u304b\u3001\u3054\u8aac\u660e\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u81e8\u5e8a\u8a66\u9a13\u4e2d\u306b\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3001CRO\u304a\u3088\u3073\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u30b7\u30fc\u30e0\u30ec\u30b9\u306b\u5354\u696d\u3059\u308b\u306e\u3092\u30b5\u30dd\u30fc\u30c8\u3059\u308b³Ô¹Ï±¬ÁÏ\u306e\u30d3\u30b8\u30e7\u30f3\u3082\u660e\u3089\u304b\u306b\u3057\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ Vault\u62c5\u5f53\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306eJen Goldsmith\u304a\u3088\u3073³Ô¹Ï±¬ÁÏ Vault\u62c5\u5f53\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306eAvril England\u306f\u3001³Ô¹Ï±¬ÁÏ Development Cloud<\/a><\/strong>\u3067\u30b0\u30ed\u30fc\u30d0\u30eb\u306b\u3001\u7814\u7a76\u3068\u958b\u767a\u5168\u4f53\u306b\u304a\u3051\u308b\u30d0\u30ea\u30a8\u30fc\u30b7\u30e7\u30f3\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3084\u5909\u66f4\u7ba1\u7406\u306a\u3069\u3092\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306b\u30d7\u30ed\u30bb\u30b9\u7ba1\u7406\u3059\u308b\u65b9\u6cd5\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n 60\u3092\u8d85\u3048\u308b\u30bb\u30c3\u30b7\u30e7\u30f3\u3068\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u306b\u306f\u3001\u6b21\u306e\u5404\u793e\u304b\u3089\u8b1b\u6f14\u8005\u3092\u304a\u8fce\u3048\u3057\u307e\u3059\u3002AbbVie\u3001Agios Pharmaceuticals\u3001Alkermes PLC\u3001Allakos\u3001Atlantic Research Group\u3001BioEnterprise\u3001Clintec\u3001Gilead Sciences, Inc.\u3001GlaxoSmithKline\u3001ICON plc\u3001Incyte Corporation\u3001Integra LifeSciences\u3001Intersect ENT\u3001Ionis Pharmaceuticals, Inc.\u3001Melinta Therapeutics Inc.\u3001Ora, Inc.\u3001Radius Health\u3001Regeneron Pharmaceuticals Inc.\u3001Replimune Group Inc.\u3001Seattle Genetics, Inc.\u3001Syneos Health\u3001Sysmex Corporation\u3001TESARO, Inc.\u3001Ultragenyx Pharmaceutical Inc.\u3001Upsher-Smith Laboratories LLC\u4ed6<\/p>\n 2018 ³Ô¹Ï±¬ÁÏ R&D Summit\u306e\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u3001\u6b21\u306e\u5404\u793e\u3067\u3059\u3002Accenture\u3001AG Mednet\u3001Amazon Web Services\u3001C3i Solutions\u3001CGI\u3001Cognizant\u3001Comprehend Systems, Inc.\u3001Deloitte\u3001EY\u3001FME\u3001Ideagen Plc\u3001LPW Training Services\u3001Mavens\u3001NNIT\u3001Qlik\u3001SDL\u3001Tata Consultancy Services\u3001Trifecta\u3001UL PURE Learning\u3001Valiance Partners<\/p>\n ³Ô¹Ï±¬ÁÏ R&D Summit\u306f\u3001³Ô¹Ï±¬ÁÏ\u306e\u304a\u5ba2\u69d8\u304a\u3088\u3073\u3054\u62db\u5f85\u5ba2\u306e\u7686\u69d8\u5411\u3051\u306e\u7121\u6599\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u8a73\u7d30\u60c5\u5831\u304a\u3088\u3073\u30a2\u30b8\u30a7\u30f3\u30c0\u5168\u4f53\u306e\u8a73\u7d30\u306f\u3001veeva.com\/R&DSummit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002 \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2018\u5e749\u670819\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-41818","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-veeva-rd"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41818"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=41818"}],"version-history":[{"count":4,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41818\/revisions"}],"predecessor-version":[{"id":41826,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41818\/revisions\/41826"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=41818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=41818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=41818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n <\/p>\n
\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067650\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April\u00a030, 2018. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"